Exelixis Inc. buy Brookline Capital Management
Start price
23.12.24
/
50%
€31.85
Target price
23.12.25
-
Performance (%)
10.55%
Price
15.12.25
€35.21
This prediction will end soon
Summary
This prediction is currently active. The prediction currently has a performance of 10.55%. This prediction currently runs until 23.12.25. The prediction end date can be changed by Brookline_Capital_Ma at any time. Brookline_Capital_Ma has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | -2.815% | -2.815% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Brookline_Capital_Ma for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) is now covered by analysts at Brookline Capital Management. They set a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat